Forian Inc. Announces Third Quarter 2025 Earnings Call Schedule

Forian Inc., a Nasdaq-listed company trading under the symbol FORA, has scheduled its third quarter 2025 financial results announcement for November 14, 2025. The company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the quarterly performance. Forian operates as a leading provider of data science driven information and analytics solutions serving multiple industries including life sciences, healthcare and financial services.

The company's financial results will be disclosed through a press release distributed prior to the scheduled conference call. Investors and interested parties can access the live webcast through the designated platform at https://edge.media-server.com/mmc/p/dyiaxrbd. This webcast provides real-time access to management's discussion of quarterly performance and strategic updates. Following the conclusion of the live event, both the earnings release and a replay of the conference call will be made available through the company's investor relations portal at www.forian.com/investors.

Forian's business model centers on delivering sophisticated data management capabilities and proprietary analytics solutions designed to optimize operational, clinical and financial performance for its clients. The company serves traditional and emerging life sciences organizations along with healthcare payers and providers. Through its recent acquisition of Kyber Data Science, Forian has expanded its service offerings to include the financial services industry, demonstrating the versatility of its data science applications across sectors.

The company has established industry leadership in acquiring, integrating and commercializing large-scale healthcare data assets. Forian's information products leverage advanced data management and data science techniques applied to comprehensive clinical data repositories. This approach enables the identification of unique relationships within data sets, creation of distinctive information assets and generation of proprietary insights that drive value for clients.

The upcoming earnings announcement holds significance for multiple stakeholders including investors, industry analysts and clients across the healthcare and financial services sectors. Quarterly financial results provide measurable indicators of Forian's growth trajectory and market position within the competitive data analytics landscape. The company's performance metrics may influence investment decisions and provide insights into broader trends affecting the healthcare analytics market.

Forian's expansion into financial services through the Kyber Data Science acquisition represents a strategic diversification that could impact the company's revenue streams and market valuation. The integration of financial services capabilities alongside existing healthcare analytics offerings positions Forian to capitalize on cross-industry data science applications. This diversification strategy may enhance the company's resilience to sector-specific economic fluctuations while creating new growth opportunities.

The conference call will likely address operational milestones, client acquisition trends and the performance of recently launched products or services. Management commentary during the earnings call typically provides context for financial results and may include updates on strategic initiatives, market expansion efforts and competitive positioning. These insights help stakeholders assess the company's execution against stated objectives and future growth potential.

Forian's continued focus on data science innovation across healthcare and financial services reflects broader industry trends toward data-driven decision making. The company's performance metrics may serve as indicators of market demand for sophisticated analytics solutions in regulated industries. As organizations increasingly rely on data insights to drive operational efficiency and competitive advantage, Forian's quarterly results provide valuable benchmarks for assessing the health of the business intelligence sector.